AUTL — Autolus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Autolus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	211	153	310	382	240
Net Total Accounts Receivable
Net Total Receivables	30.5	29.7	26.3	29	24.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	249	197	347	426	275
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	51.6	89.7	52.3	58.4	95.7
Net Intangible Assets
Other Long Term Assets
Total Assets	304	294	406	490	375
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	25	33.6	28.6	46.4	44.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.7	84.2	92.2	192	264
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	255	210	313	299	111
Total Liabilities & Shareholders' Equity	304	294	406	490	375